STOCK TITAN
  1. Home
  2. News
  3. CRMD

CorMedix Inc - CRMD STOCK NEWS

IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. Announces Partnership With The Leapfrog Group
partnership
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
fda approval
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
earnings
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023
conferences earnings
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
conferences
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology
clinical trial
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
conferences
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
IMPACT
SENTIMENT
CRMD : Nasdaq
CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update
earnings
Stock CRMD logo
CorMedix Inc

Nasdaq:CRMD

CRMD Rankings

#4440 Ranked by Market Cap
#2126 Ranked by Stock Gains
N/A Ranked by Dividends

CRMD Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Berkeley Heights

About CRMD

cormedix inc. is a company based out of 745 route 202-206, suite 303, bridgewater, nj, united states.